Immuron Limited
IMRN | NASDAQ
$1.25
+$0.03 (+2.46%)
At close: Sep 21, 2026, 3:59 PM ET
$1.23
-$0.02 (-1.60%)
Pre-market:
Sep 22, 2026, 5:52 AM ET
Fiscal Year Period Ending | FY 2026 Jun 29, 2026 | FY 2025 Jun 29, 2025 | FY 2024 Jun 29, 2024 | FY 2023 Jun 29, 2023 | FY 2022 Jun 29, 2022 | FY 2021 Jun 29, 2021 |
|---|---|---|---|---|---|---|
Revenue | 7.55M | 7.29M | 4.9M | 1.8M | 765.19K | 145.78K |
Cost of Revenue | 2.68M | 2.52M | 1.57M | 64.63K | 241.69K | 810.84K |
Gross Profit | 4.87M | 4.77M | 3.34M | 1.74M | 523.5K | -665.06K |
Operating Income | -4.63M | -5.34M | -5.8M | -3.57M | -2.87M | -8.38M |
Interest Income | n/a | 135.87K | 327.76K | 116.32K | 21.79K | 9.2K |
Pretax Income | -4.36M | -5.22M | -6.94M | -3.79M | -2.85M | -8.38M |
Net Income | -3.75M | -5.22M | -6.94M | -3.79M | -2.85M | -8.38M |
Selling & General & Admin | 7.61M | 7.94M | 6.59M | 5.15M | 3.94M | 6.38M |
Research & Development | n/a | 3.6M | 5.38M | 2.59M | 657.72K | 1.37M |
Other Expenses | 1.89M | -1.42M | -2.82M | -2.43M | -1.21M | -34.58K |
Operating Expenses | 9.5M | 10.11M | 9.14M | 5.31M | 3.39M | 7.71M |
Interest Expense | 14.39K | 7.31K | 7.58K | 9.65K | 6.18K | 13.76K |
Selling & Marketing Expenses | n/a | 3.45M | 2.03M | 927.42K | 416.54K | 287.68K |
Cost & Expenses | 12.18M | 12.63M | 10.7M | 5.37M | 3.64M | 8.53M |
Income Tax Expense | -609.99K | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 7.44M | 5.77M | 5.7M | 5.69M | 5.69M | 5.53M |
Shares Outstanding (Diluted) | 7.44M | 5.77M | 5.7M | 5.69M | 5.69M | 5.53M |
EPS (Basic) | -0.50 | -0.90 | -1.22 | -0.66 | -0.50 | -1.52 |
EPS (Diluted) | -0.50 | -0.90 | -1.22 | -0.66 | -0.50 | -1.52 |
EBITDA | -4.63M | -5.31M | -5.17M | -3.36M | -3.09M | -7.95M |
EBIT | -4.63M | -5.36M | -5.22M | -3.41M | -3.12M | -7.96M |
Depreciation & Amortization | n/a | 49.69K | 45.98K | 48.66K | 26.61K | 5.04K |
Add to Watchlist
Select watchlists to add or remove IMRN